EUVIMEDEUVIMED entdecken
Open Access

Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1

Rui Hu, Huihui Hou, Yao Li, Minghui Zhang, Xin Li, Yanzhong Chen, Ying Guo, Hongyin Sun, Shuang Zhao, Mengting Liao, Dongsheng Cao, Qin Yan und 2 weitere

Theranostics · 2024 · 14 (2) · 593-607

DOI: 10.7150/thno.85437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Rui Hu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya H…. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaHumansNuclear ProteinsTranscription FactorsProtein Kinase InhibitorsPyridonesMitogen-Activated Protein Kinase KinasesProto-Oncogene Proteins B-rafCell Line, TumorBromodomain Containing ProteinsCell Cycle Proteins

Stichwörter der Autor:innen

BET inhibitorBRD4MEK inhibitorMelanomaYAP1

Substanzen

Nuclear ProteinsTranscription FactorsProtein Kinase InhibitorsPyridonesMitogen-Activated Protein Kinase KinasesProto-Oncogene Proteins B-rafBRD4 protein, humanBromodomain Containing ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Pathology, Yale School of Medicine, New Haven, CT 06520, USA.
  • Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • The first clinical college of Chongqing Medical University, Chongqing, China.
  • Health Management of Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Zitieren

APA

Hu, R., Hou, H., Li, Y., Zhang, M., Li, X., Chen, Y., Guo, Y., Sun, H., Zhao, S., Liao, M., Cao, D., Yan, Q., Chen, X., & Yin, M. (2024). Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. Theranostics, 14(2), 593-607. https://doi.org/10.7150/thno.85437

Vancouver

Hu R, Hou H, Li Y, Zhang M, Li X, Chen Y, et al. Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. Theranostics. 2024;14(2):593-607. doi:10.7150/thno.85437

BibTeX
@article{Hu2024,
  author = {Hu, Rui and Hou, Huihui and Li, Yao and Zhang, Minghui and Li, Xin and Chen, Yanzhong and Guo, Ying and Sun, Hongyin and Zhao, Shuang and Liao, Mengting and Cao, Dongsheng and Yan, Qin and Chen, Xiang and Yin, Mingzhu},
  title = {Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {2},
  pages = {593--607},
  doi = {10.7150/thno.85437}
}
Kostenlos starten →